These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 316692)

  • 21. Efficacy of a combination thromboxane receptor antagonist and lipoxygenase inhibitor in traumatic shock.
    Levitt MA; Stahl G; Lefer AM
    Resuscitation; 1988 Jul; 16(3):211-20. PubMed ID: 2845544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effects of oligotide, a novel oligodeoxyribonucleotide, in murine traumatic shock.
    Skurk C; Nuss C; Lefer AM
    Shock; 1995 Jan; 3(1):13-20. PubMed ID: 7531603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-shock properties of the prostacyclin analog, iloprost, in traumatic shock.
    Levitt MA; Lefer AM
    Prostaglandins Leukot Med; 1986 Dec; 25(2-3):175-85. PubMed ID: 2434958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic and surgical modulation of myocardial depressant factor formation and action during shock.
    Lefer AM
    Prog Clin Biol Res; 1983; 111():111-23. PubMed ID: 6191336
    [No Abstract]   [Full Text] [Related]  

  • 25. Preservation of cellular integrity as a protective mechanism of dexamethasone in hemorrhagic shock in the cat.
    Trachte GJ; Lefer AM
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):309-20. PubMed ID: 677964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial effects of prostaglandin E1 infusion in experimental traumatic shock.
    Levitt MA; Lefer AM
    Crit Care Med; 1987 Aug; 15(8):769-73. PubMed ID: 3608533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effects of a platelet activating factor (PAF) antagonist and its combined treatment with prostaglandin (PG) E1 in traumatic shock.
    Terashita Z; Stahl GL; Lefer AM
    J Cardiovasc Pharmacol; 1988; 12(5):505-11. PubMed ID: 2468048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial actions of a free radical scavenger in traumatic shock and myocardial ischemia.
    Lefer AM; Araki H; Okamatsu S
    Circ Shock; 1981; 8(3):273-82. PubMed ID: 7249259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of a novel thromboxane analog in lethal traumatic shock.
    Lefer AM; Araki H; Smith JB; Nicolaou KC; Magolda RL
    Prostaglandins Med; 1979 Sep; 3(3):139-46. PubMed ID: 552102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxygen-derived free radicals induced cellular injury in superior mesenteric artery occlusion shock: protective effect of superoxide dismutase.
    Wang JH; Chen HS; Wang T; Diao YF; Tian KL
    Circ Shock; 1990 Sep; 32(1):31-41. PubMed ID: 2208605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salutary actions of nimodipine in traumatic shock.
    Lefer AM; Carrow BA
    Life Sci; 1981 Sep; 29(13):1347-53. PubMed ID: 7289786
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of angiotensin II receptor blockade by [Sar1-Ala8]angiotensin II in hemorrhagic shock.
    Trachte GJ; Lefer AM
    Am J Physiol; 1979 Feb; 236(2):H280-5. PubMed ID: 311160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of aprotinin in a model of uncontrolled hemorrhagic shock.
    Paran H; Gutman M; Mayo A
    Am J Surg; 2005 Sep; 190(3):463-6. PubMed ID: 16105537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysosomal and ATP changes after renal-stalk clamping in rats. I. Protective action of Trasylol.
    Horpácsy G; Zinsmeyer J; Schröder K; Schnells G
    Circ Shock; 1977; 4(1):55-68. PubMed ID: 21756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of adenosine, an adenosine-A1 antagonist, and their combination in splanchnic occlusion shock in rats.
    Karasawa A; Rochester JA; Lefer AM
    Circ Shock; 1992 Feb; 36(2):154-61. PubMed ID: 1582007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for a role of platelet activating factor in hypovolemic shock in the rat.
    Zingarelli B; Squadrito F; Bussolino F; Calapai G; Altavilla D; Ioculano M; Campo GM; Canale P; Caputi AP
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):123-34. PubMed ID: 8012759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of urinastatin on an energy metabolism disorder during shock].
    Sato M; Ishikawa H; Niho T; Mizota M
    Nihon Yakurigaku Zasshi; 1986 Sep; 88(3):195-203. PubMed ID: 2431982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of aprotinin on the mean arterial pressure, carotid artery blood flow, and hindlimb vascular resistance in the live rat, and pulmonary vascular resistance in the isolated perfused rat lung.
    Jahr JS; Kaye AD; Kang B; Feng CJ; Nossaman BD
    J Med; 1995; 26(1-2):31-42. PubMed ID: 7561529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial actions of CP-0127, a novel bradykinin receptor antagonist, in murine traumatic shock.
    Christopher TA; Ma XL; Gauthier TW; Lefer AM
    Am J Physiol; 1994 Mar; 266(3 Pt 2):H867-73. PubMed ID: 8160833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aprotinin and myocardial performance in shock.
    David D; Rogel S
    Acta Anaesthesiol Belg; 1976; 27 suppl():356-62. PubMed ID: 1087824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.